title: Does toxicity predict efficacy? Insight into the mechanism of action of lapatinib.
authors.affiliation: German Breast Group, Neu-Isenburg, Germany; University Hospital of Udine, Udine, Italy.
authors.forename: Caterina
authors.initials: C
authors.lastname: Fontanella
authors.affiliation: German Breast Group, Neu-Isenburg, Germany.
authors.forename: Bianca
authors.initials: B
authors.lastname: Lederer
authors.affiliation: German Breast Group, Neu-Isenburg, Germany.
authors.forename: Valentina
authors.initials: V
authors.lastname: Nekljudova
authors.affiliation: HELIOS Klinikum Berlin Buch, Berlin, Germany.
authors.forename: Michael
authors.initials: M
authors.lastname: Untch
authors.affiliation: German Breast Group, Neu-Isenburg, Germany.
authors.forename: Gunter
authors.initials: G
authors.lastname: von Minckwitz
authors.affiliation: German Breast Group, Neu-Isenburg; and Sana-Klinikum Offenbach, Germany Sibylle.Loibl@germanbreastgroup.de.
authors.forename: Sibylle
authors.initials: S
authors.lastname: Loibl
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000188:drug therapy*; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology*; D003967:Diarrhea / Q000139:chemically induced*; D003875:Drug Eruptions / Q000209:etiology*; D005260:Female; D006801:Humans; D020360:Neoadjuvant Therapy / Q000379:methods*; D011799:Quinazolines / Q000009:adverse effects*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D011799:Quinazolines